Volume 26, Issue 2 p. 164
Mutation in Brief
Free Access

Functional in vitro characterization of 14 SMPD1 mutations identified in Italian patients affected by Niemann Pick Type B disease

Andrea Dardis

Andrea Dardis

Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Italy

Search for more papers by this author
Stefania Zampieri

Stefania Zampieri

Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Italy

Search for more papers by this author
Mirella Filocamo

Mirella Filocamo

Laboratorio Diagnosi Pre-Postnatale Malattie Metaboliche, I.R.C.C.S. G. Gaslini, Genova, Italy

Search for more papers by this author
Alberto Burlina

Alberto Burlina

Division of Metabolic Disorders, Department of Pediatrics, University Hospital, Padova, Italy

Search for more papers by this author
Bruno Bembi

Corresponding Author

Bruno Bembi

Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Italy

Unità di Malattie Metaboliche I.R.C.C.S. Burlo Garofolo, Via dell'Istria 65/1, (34100) Trieste, ItalySearch for more papers by this author
Maria Gabriela Pittis

Maria Gabriela Pittis

Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Italy

Search for more papers by this author
First published: 11 July 2005
Citations: 29

Communicated by William S. Sly

Online Citation: Human Mutation, Mutation in Brief #824 (2005) Online http://www3.interscience.wiley.com/homepages/38515/pdf/824.pdf

Abstract

Niemann Pick disease (NPD) is an autosomal recessive lysosomal storage disorder caused by the deficient activity of acid sphingomyelinase due to mutations in the SMPD1 gene. We functionally characterized three novel SMPD1 mutations and 11 already reported in the Italian population. Mutant alleles were studied for enzyme activity and protein processing in transiently transfected COS-1 cells. The c.96G>A, c.100delG, c.565dupC, and c.575dupC (p.W32X, p.G34fsX42, p.P189fsX1, and p.P192fs14) alleles expressed no immunoreactive protein and consequently no enzyme activity. In contrast, cells transfected with mutants c.308T>C, c.389T>C, c.674T>C, c.732G>C, c.841G>A, c.1687G>A, c.1799G>A, and c.1799G>C (p.L103P, p.V130A, p.L225P, p.W244C, p.A281T, p.D563Y, p.R600H, p.R600P) expressed protein levels comparable to wild-type ASM expressing cells. Only three of these constructs, c.389T>C, c.1687G>A, and c.1799G>A (p.V130A, p.D563Y, p.R600H), retained residual activity while the other five expressed very low or no enzyme activity. As expected, the c.1669underscore;1670delGT (p.V557fsX18) mutant expressed a completely inactive truncated protein. Interestingly, the c.2T>G (p.M1_W32del) mutant expressed 26.9% of the wild type activity, even though no ASM protein was detected by Western blot analysis, suggesting that the amount of produced enzyme is below detection levels. The results presented in this study are consistent with the wide phenotype variability found in NP type B patients and provide valuable insights into the molecular basis of the disease. © 2005 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.